[Ala144]-PLP (139-151) A144-PLP(139-151) is a peptide derived from the proteolipid protein (PLP) with an alanine substitution at position 144. The peptide is involved in myelination processes and is a key target for studying multiple sclerosis. Researchers use it to investigate immune responses against PLP and its role in autoimmune diseases affecting the nervous system.
CAT No: P14001
1. Immune responses to homocitrulline-and citrulline-containing peptides in rheumatoid arthritis
4. Low bone turnover and low BMD in Down syndrome: effect of intermittent PTH treatment
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More